• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 辅助蛋白 Vpu 下调过氧化物酶体生物发生。

The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.

机构信息

Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada.

Laboratory of Human Retrovirology, Institut de Recherches Cliniques de Montréal, Montréal, Quebec, Canada.

出版信息

mBio. 2020 Mar 3;11(2):e03395-19. doi: 10.1128/mBio.03395-19.

DOI:10.1128/mBio.03395-19
PMID:32127461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7064786/
Abstract

Human immunodeficiency virus type 1 (HIV-1) establishes lifelong infections in humans, a process that relies on its ability to thwart innate and adaptive immune defenses of the host. Recently, we reported that HIV-1 infection results in a dramatic reduction of the cellular peroxisome pool. Peroxisomes are metabolic organelles that also function as signaling platforms in the innate immune response. Here, we show that the HIV-1 accessory protein Vpu is necessary and sufficient for the depletion of cellular peroxisomes during infection. Vpu induces the expression of four microRNAs that target mRNAs encoding proteins required for peroxisome formation and metabolic function. The ability of Vpu to downregulate peroxisomes was found to be dependent upon the Wnt/β-catenin signaling pathway. Given the importance of peroxisomes in innate immune signaling and central nervous system function, the roles of Vpu in dampening antiviral signaling appear to be more diverse than previously realized. Finally, our findings highlight a potential role for Wnt/β-catenin signaling in peroxisome homeostasis through modulating the production of biogenesis factors. People living with HIV can experience accelerated aging and the development of neurological disorders. Recently, we reported that HIV-1 infection results in a dramatic loss of peroxisomes in macrophages and brain tissue. This is significant because (i) peroxisomes are important for the innate immune response and (ii) loss of peroxisome function is associated with cellular aging and neurodegeneration. Accordingly, understanding how HIV-1 infection causes peroxisome depletion may provide clues regarding how the virus establishes persistent infections and, potentially, the development of neurological disorders. Here, we show that the accessory protein Vpu is necessary and sufficient for the induction of microRNAs that target peroxisome biogenesis factors. The ability of Vpu to downregulate peroxisome formation depends on the Wnt/β-catenin pathway. Thus, in addition to revealing a novel mechanism by which HIV-1 uses intracellular signaling pathways to target antiviral signaling platforms (peroxisomes), we have uncovered a previously unknown link between the Wnt/β-catenin pathway and peroxisome homeostasis.

摘要

人类免疫缺陷病毒 1 型(HIV-1)在人类中建立终身感染,这一过程依赖于其逃避宿主固有和适应性免疫防御的能力。最近,我们报道 HIV-1 感染导致细胞过氧化物酶体池的急剧减少。过氧化物酶体是代谢细胞器,在固有免疫反应中也作为信号平台发挥作用。在这里,我们表明 HIV-1 辅助蛋白 Vpu 是感染过程中细胞过氧化物酶体耗竭所必需和充分的。Vpu 诱导靶向编码过氧化物酶体形成和代谢功能所需蛋白的 mRNA 的四个 microRNA 的表达。发现 Vpu 下调过氧化物酶体的能力依赖于 Wnt/β-连环蛋白信号通路。鉴于过氧化物酶体在固有免疫信号和中枢神经系统功能中的重要性,Vpu 减弱抗病毒信号的作用似乎比以前认识到的更为多样化。最后,我们的研究结果强调了 Wnt/β-连环蛋白信号通路在通过调节生物发生因子的产生来维持过氧化物酶体稳态方面的潜在作用。HIV 感染者可能会经历加速衰老和神经紊乱的发展。最近,我们报道 HIV-1 感染导致巨噬细胞和脑组织中过氧化物酶体的大量丢失。这很重要,因为 (i) 过氧化物酶体对固有免疫反应很重要,以及 (ii) 过氧化物酶体功能的丧失与细胞衰老和神经退行性变有关。因此,了解 HIV-1 感染如何导致过氧化物酶体耗竭可能提供有关病毒如何建立持续性感染以及潜在神经紊乱发展的线索。在这里,我们表明辅助蛋白 Vpu 是诱导靶向过氧化物酶体生物发生因子的 microRNA 的必需和充分条件。Vpu 下调过氧化物酶体形成的能力取决于 Wnt/β-连环蛋白途径。因此,除了揭示 HIV-1 使用细胞内信号通路靶向抗病毒信号平台(过氧化物酶体)的新机制外,我们还发现了 Wnt/β-连环蛋白途径与过氧化物酶体稳态之间以前未知的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/a8f96317d961/mBio.03395-19-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/6d277a152c63/mBio.03395-19-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/8185bd1d3421/mBio.03395-19-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/edb806977c90/mBio.03395-19-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/387f74f05e8d/mBio.03395-19-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/8fc813bd87cc/mBio.03395-19-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/f5e5ea8842d9/mBio.03395-19-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/3b5e8eabbc6b/mBio.03395-19-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/c719688ebf4b/mBio.03395-19-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/a8f96317d961/mBio.03395-19-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/6d277a152c63/mBio.03395-19-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/8185bd1d3421/mBio.03395-19-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/edb806977c90/mBio.03395-19-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/387f74f05e8d/mBio.03395-19-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/8fc813bd87cc/mBio.03395-19-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/f5e5ea8842d9/mBio.03395-19-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/3b5e8eabbc6b/mBio.03395-19-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/c719688ebf4b/mBio.03395-19-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb3/7064786/a8f96317d961/mBio.03395-19-f0009.jpg

相似文献

1
The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.HIV-1 辅助蛋白 Vpu 下调过氧化物酶体生物发生。
mBio. 2020 Mar 3;11(2):e03395-19. doi: 10.1128/mBio.03395-19.
2
The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4 T cells.HIV-1 辅助蛋白 Nef 和 Vpu 下调 CD4 T 细胞中总 CD28 和细胞表面 CD28 的表达。
Retrovirology. 2018 Jan 12;15(1):6. doi: 10.1186/s12977-018-0388-3.
3
Decreased, Deformed, Defective-How HIV-1 Vpu Targets Peroxisomes.减少、变形、缺陷——HIV-1 Vpu 如何靶向过氧化物酶体。
mBio. 2020 May 26;11(3):e00967-20. doi: 10.1128/mBio.00967-20.
4
HIV-1 Vpu Promotes Phagocytosis of Infected CD4 T Cells by Macrophages through Downregulation of CD47.HIV-1 Vpu通过下调CD47促进巨噬细胞对感染的CD4 T细胞的吞噬作用。
mBio. 2021 Aug 31;12(4):e0192021. doi: 10.1128/mBio.01920-21. Epub 2021 Aug 24.
5
HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.HIV病毒蛋白U干扰核因子κB的活性,但不干扰干扰素调节因子3。
J Virol. 2015 Oct;89(19):9781-90. doi: 10.1128/JVI.01596-15. Epub 2015 Jul 15.
6
Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.传播/创始者慢性 B 组 HIV-1 Vpu 活性和一个影响病毒粒子释放的 C 末端多态性。
J Virol. 2014 May;88(9):5062-78. doi: 10.1128/JVI.03472-13. Epub 2014 Feb 26.
7
Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.Vpu是HIV-1感染细胞中四跨膜蛋白下调的主要决定因素。
J Virol. 2015 Mar;89(6):3247-55. doi: 10.1128/JVI.03719-14. Epub 2015 Jan 7.
8
HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4 T Cells by NK Cells.HIV-1病毒蛋白U(Vpu)下调细胞间黏附分子-1(ICAM-1)的表达,导致自然杀伤细胞(NK细胞)对受感染CD4 T细胞的杀伤作用减弱。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.02442-16. Print 2017 Apr 15.
9
HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.HIV-1 Nef和Vpu干扰L-选择素(CD62L)的细胞表面表达,以抑制感染的CD4 + T淋巴细胞中的粘附和信号传导。
J Virol. 2015 May;89(10):5687-700. doi: 10.1128/JVI.00611-15. Epub 2015 Mar 11.
10
MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages.Vpu 诱导 microRNA-25/93 作为一种对抗 MARCH1 对巨噬细胞中 HIV-1 感染性限制的机制。
mBio. 2023 Oct 31;14(5):e0195023. doi: 10.1128/mbio.01950-23. Epub 2023 Sep 29.

引用本文的文献

1
The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses.Wnt/β-连环蛋白信号通路对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和其他致病性RNA病毒的复制至关重要。
Npj Viruses. 2024 Feb 21;2(1):6. doi: 10.1038/s44298-024-00018-4.
2
Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis.miRNA-26a 的下调通过 HIV-1 增强 CD59 的表达和包装,影响病毒对抗体依赖的补体介导的溶解的敏感性。
Viruses. 2024 Jul 4;16(7):1076. doi: 10.3390/v16071076.
3
Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered.

本文引用的文献

1
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.对丙型肝炎病毒感染细胞和肝脏的代谢组、蛋白质组和转录组进行联合分析,以鉴定与疾病发展相关的途径。
Gastroenterology. 2019 Aug;157(2):537-551.e9. doi: 10.1053/j.gastro.2019.04.003. Epub 2019 Apr 9.
2
HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses.HIV-1 Vpu 是一种有效的 NF-κB 诱导的抗病毒免疫反应的转录抑制剂。
Elife. 2019 Feb 5;8:e41930. doi: 10.7554/eLife.41930.
3
Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
抗病毒因素及其被 HIV-1 拮抗:许多未被发现的还有更多有待发现。
J Mol Cell Biol. 2024 Jul 29;16(2). doi: 10.1093/jmcb/mjae005.
4
The peroxisome: an update on mysteries 3.0.过氧化物酶体:更新的未解之谜 3.0 版。
Histochem Cell Biol. 2024 Feb;161(2):99-132. doi: 10.1007/s00418-023-02259-5. Epub 2024 Jan 20.
5
Peroxisomes and Viruses: Overview on Current Knowledge and Experimental Approaches.过氧化物酶体与病毒:现有知识与实验方法概述
Methods Mol Biol. 2023;2643:271-294. doi: 10.1007/978-1-0716-3048-8_19.
6
Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients.HIV-1 快速进展者患者中不稳定 HLA-C 变异体的流行率增加。
Int J Mol Sci. 2022 Nov 27;23(23):14852. doi: 10.3390/ijms232314852.
7
DDX5: an expectable treater for viral infection- a literature review.DDX5:病毒感染的一种潜在治疗手段——文献综述
Ann Transl Med. 2022 Jun;10(12):712. doi: 10.21037/atm-22-2375.
8
Serum Exosomal microRNA Profiling in AIDS Complicated with Infection.艾滋病合并感染患者血清外泌体微小RNA谱分析
Infect Drug Resist. 2021 Nov 25;14:4931-4948. doi: 10.2147/IDR.S338321. eCollection 2021.
9
Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells.过氧化物酶体在感染 SARS-CoV-2 的细胞中表现出结构和基质蛋白含量受损。
Mol Biol Cell. 2021 Jul 1;32(14):1273-1282. doi: 10.1091/mbc.E21-02-0074. Epub 2021 May 19.
10
From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1.从进入到逸出:HIV-1对细胞过程的策略性利用
Front Microbiol. 2020 Dec 4;11:559792. doi: 10.3389/fmicb.2020.559792. eCollection 2020.
经典 WNT/β-连环蛋白通路与过氧化物酶体增殖物激活受体 γ 的相反相互作用:胶质瘤的潜在治疗靶点。
Neurosci Bull. 2018 Jun;34(3):573-588. doi: 10.1007/s12264-018-0219-5. Epub 2018 Mar 26.
4
Targeted Elimination of Peroxisomes During Viral Infection: Lessons from HIV and Other Viruses.靶向消除病毒感染期间的过氧化物酶体:来自 HIV 和其他病毒的教训。
DNA Cell Biol. 2018 May;37(5):417-421. doi: 10.1089/dna.2018.4153. Epub 2018 Feb 14.
5
Unbalanced lipolysis results in lipotoxicity and mitochondrial damage in peroxisome-deficient mutants.失衡的脂解导致过氧化物酶体缺陷型 突变体中的脂毒性和线粒体损伤。
Mol Biol Cell. 2018 Feb 15;29(4):396-407. doi: 10.1091/mbc.E17-08-0535. Epub 2017 Dec 27.
6
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells.葛兰素史克公司生产的糖原合成酶激酶3(GSK3)抑制剂锂,在人胶质母细胞瘤细胞中会使GSK3的底物β-连环蛋白发生意外的过度磷酸化。
Biol Open. 2018 Jan 26;7(1):bio030874. doi: 10.1242/bio.030874.
7
Multiprotein complexes governing Wnt signal transduction.调控 Wnt 信号转导的多蛋白复合物。
Curr Opin Cell Biol. 2018 Apr;51:42-49. doi: 10.1016/j.ceb.2017.10.008. Epub 2017 Nov 15.
8
MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology.HIV感染期间上调的微小RNA靶向过氧化物酶体生物发生因子:对病毒生物学、疾病机制和神经病理学的影响。
PLoS Pathog. 2017 Jun 8;13(6):e1006360. doi: 10.1371/journal.ppat.1006360. eCollection 2017 Jun.
9
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.Wnt/β-连环蛋白信号通路、疾病与新兴治疗模式。
Cell. 2017 Jun 1;169(6):985-999. doi: 10.1016/j.cell.2017.05.016.
10
Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.通过靶向β-连环蛋白/Tcf4相互作用发现Wnt/β-连环蛋白信号通路的小分子抑制剂
Exp Biol Med (Maywood). 2017 Jun;242(11):1185-1197. doi: 10.1177/1535370217708198. Epub 2017 May 5.